Latvia Pharmaceutical and Medical Goods Expenditure Share (2024)
Latvia's Pharmaceutical and Medical Goods Expenditure Share: 22.4 % of current health expenditure in 2024, -2pp YoY. Eurostat (HLTH_SHA11_HC), 2013–2024.
Latvia (2024)
22.4
% of current health expenditure
-2pp YoY
YoY Change
-2pp
percentage points
Trend
down
Series length
12
years of data
Data
| Year | % of current health expenditure | YoY Change |
|---|---|---|
| 2024 | 22.4 | -2pp |
| 2023 | 24.4 | +2.2pp |
| 2022 | 22.2 | +2.6pp |
| 2021 | 19.6 | -6.6pp |
| 2020 | 26.2 | -1pp |
| 2019 | 27.2 | -2.8pp |
| 2018 | 30 | -1.1pp |
| 2017 | 31.1 | -0.8pp |
| 2016 | 31.9 | +1.4pp |
| 2015 | 30.5 | +0.4pp |
| 2014 | 30.1 | +0.2pp |
| 2013 | 29.9 | n/a |
About this Dataset
Latvia recorded 22.4 % of current health expenditure in 2024. The latest change was -2pp. Across 2013–2024 the series ranges from 19.6 % of current health expenditure in 2021 to 31.9 % of current health expenditure in 2016.
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Latvia.
Data sourced from Eurostat via SDMX REST API. Values use harmonised methodology intended for cross-country comparison.
Frequently Asked Questions
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Latvia. It is published by Eurostat and updated annually.
The most recent observation covers 2024. Eurostat typically publishes this series with a lag of several months after the reference period. The series runs 2013–2024 (12 observations).
The series peaked at 31.9 % of current health expenditure in 2016 and reached its lowest recorded value of 19.6 % of current health expenditure in 2021. The latest reading is 22.4 % of current health expenditure in 2024. The latest change was -2pp.